An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome.

Citation metadata

Author: Brian E. Lacy
Date: Sept. 2020
From: Journal of Family Practice(Vol. 69, Issue 7)
Publisher: Jobson Medical Information LLC
Document Type: Article
Length: 4,549 words
Lexile Measure: 1700L

Document controls

Main content

Article Preview :

CONTINUING MEDICAL EDUCATION

LEARNING OBJECTIVES

* Describe the multiple symptoms of irritable bowel syndrome (IBS) and their impact on quality of life

* Use a staged strategy for the diagnostic evaluation of IBS based on history and physical examination, including Rome IV criteria

* Individualize treatment for IBS based on an evolving understanding of pathophysiologic mechanisms using evidence-based therapies to address patient concerns and improve quality of life

TARGET AUDIENCE

Family physicians and clinicians who wish to gain increased knowledge and greater competency regarding primary care management of irritable bowel syndrome.

DISCLOSURES

As a continuing medical education provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Primary Care Education Consortium (PCEC) requires any individual in a position to influence educational content to disclose any financial interest or other personal relationship with any commercial interest. This includes any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by the faculty.

Dr. Lacy discloses that he serves on scientific advisory boards for Salix, Arena, and Ironwood Pharmaceuticals and has received an unrelated grant from Salix.

Gregory Scott, PharmD, RPh, editorial support, discloses he has no real or apparent conflicts of interests to report. Additional PCEC staff report no conflicts of interest.

SPONSORSHIP

This activity is sponsored by Primary Care Education Consortium, in collaboration with the Primary Care Metabolic Group.

ACCREDITATION

The Primary Care Education Consortium is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

AMA PRA Category 1--Primary Care Education Consortium designates this enduring material for a maximum of 1.0 AMA PRA Category 1 credits)[TM]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME is available September 1, 2020 to August 31,2021.

METHOD OF PARTICIPATION

PHYSICIANS: To receive CME credit, please read the journal article and, on completion, go to www.pceconsortium. org/ibs to complete the online post-test and receive your certificate of completion.

PHYSICIAN ASSISTANTS AND NURSE PRACTITIONERS: AANP, ANCC, and AAPA accept certificates of participation of educational activities certified for AMA PRA Category 1 Credit[TM] from organizations accredited by ACCME.

SUPPORTER

This article is supported by an educational grant from Allergan and Ironwood Pharmaceuticals.

FACULTY

Brian E. Lacy, MD, PhD, FACG, Co-Editor in Chief, American Journal of Gastroenterology, Professor of Medicine, Senior Associate Consultant, Mayo Clinic, Jacksonville, FL

ACKNOWLEDGMENT

Editorial support was provided by Gregory Scott, PharmD, RPh, at the Primary Care Education Consortium (PCEC).

BURDEN OF DISEASE

Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder that affects 10% to 15% of the US population. (1) IBS is more prevalent in women and in persons younger than 50 years. (2) IBS is characterized by recurrent abdominal pain and altered bowel habits; bloating and distention frequently coexist....

Source Citation

Source Citation   

Gale Document Number: GALE|A638801689